Internal Reference Number: FOI_7126
Date Request Received: 14/04/2023 00:00:00
Date Request Replied To: 05/05/2023 00:00:00
This response was sent via: By Email
Request Summary: Dermatological conditions
Request Category: Companies
Question Number 1: How many patients were treated in the last 4 months by the dermatology department with each of the following products: • Abrocitinib • Acitretin • Alitretinoin • Azathioprine • Baricitinib • Ciclosporin • Dupilumab • Methotrexate • Mycophenolate mofetil • Pimecrolimus • Phototherapy (UVB or PUVA) • Tacrolimus ointment • Tralokinumab • Upadacitinib | |
Answer To Question 1: Abrocitinib 0 Acitretin 15 Alitretinoin <5 Azathioprine <5 Baricitinib 0 Ciclosporin 9 Dupilumab 18 Methotrexate 19 Mycophenolate 0 Pimecrolimus 13 Phototherapy 74 Tacrolimus 25 Tralokinumab <5 Upadacitinib 0 | |
Question Number 2: Of the patients treated in the last 4 months with any of the products listed in question 1, please provide the number of patients by the following age group: • Age 6-11 • Age 12-17 • Age 18 and above | |
Answer To Question 2: Age 6-11 = <5 Age 12-17 = <5 Age 18+ = 71 | |
Question Number 3: If possible, could you please provide the number of patients treated in the last 4 months for Atopic Dermatitis ONLY with: • Azathioprine • Ciclosporin • Methotrexate • Mycophenolate mofetil • Phototherapy (UVB or PUVA) | |
Answer To Question 3: Azathioprine <5 Ciclosporin <5 Methotrexate 5 Mycophenolate mofetil 0 UVB <5 | |
To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.